Skip to main content
Clinical Trials/NCT05439850
NCT05439850
Recruiting
Phase 4

Arthroscopic Rotator Cuff Repair Augmented with Bioinductive Implant for Full-Thickness Tears: a Randomized Controlled Study

Henry Ford Health System1 site in 1 country78 target enrollmentAugust 16, 2022

Overview

Phase
Phase 4
Intervention
arthroscopic rotator cuff repair
Conditions
Rotator Cuff Tears
Sponsor
Henry Ford Health System
Enrollment
78
Locations
1
Primary Endpoint
Rotator cuff repair integrity
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The purpose of this randomized-controlled study is to compare outcomes of arthroscopic rotator cuff repair augmented with a Bioinductive Implant (study group) to standard arthroscopic rotator cuff repair (control group). The primary outcome of this study is rotator cuff repair integrity (absence of full- or partial-thickness defect) demonstrated on ultrasound at 1-year postoperatively. The investigators hypothesize that the study group will have higher rates of repair integrity demonstrated on ultrasound at 1-year postoperatively.

Detailed Description

A bioinductive patch is an implant that may foster tendon regrowth and healing following surgery. Patients will be randomized into one of two groups: control and investigational. All surgical patients will have failed non-surgical/conservative options for 6 weeks. Patients in the "control group" will receive the standard surgery (arthroscopic rotator cuff repair) . Patients in the "experimental group" will receive the same surgical treatment, with the addition of the bioinductive patch. This patch will be implanted during surgery. Then, using a combination of ultrasound studies and other measures, the investigators will assess how well the patch works compared to surgery alone.

Registry
clinicaltrials.gov
Start Date
August 16, 2022
End Date
December 1, 2027
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Stephanie Muh, MD

Deputy Service Chief, Principal Investigator

Henry Ford Health System

Eligibility Criteria

Inclusion Criteria

  • Indicated and scheduled for arthroscopic rotator cuff repair.
  • Full-thickness medium (1-3 cm), large (3-5 cm), and massive (\>5 cm) rotator cuff tears involving the supraspinatus and/or infraspinatus tendons demonstrated on magnetic resonance or ultrasound imaging.
  • Chronic, degenerative rotator cuff tears.
  • Ability to read and understand English.
  • Age ≥18 years
  • Patient failed ≥6 weeks of conservative treatment, which included structured, in-person physical therapy or documented home therapy

Exclusion Criteria

  • Patient scheduled for open or mini-open rotator cuff repair
  • Prior surgery of affected shoulder (except diagnostic arthroscopy)
  • Partial-thickness rotator cuff tears
  • Small (\<1 cm) rotator cuff tears
  • Rotator cuff tears involving the subscapularis tendon
  • Acute and traumatic rotator cuff tears
  • Active infection
  • Autoimmune and rheumatologic disorders, including rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus

Arms & Interventions

Control Group

Surgical treatment alone, consisting of arthroscopic rotator cuff repair. Ultrasound postoperatively at 1 year.

Intervention: arthroscopic rotator cuff repair

Control Group

Surgical treatment alone, consisting of arthroscopic rotator cuff repair. Ultrasound postoperatively at 1 year.

Intervention: Ultrasound Imaging

Study Group

Identical surgical treatment as control group plus bio-inductive patch implant. Ultrasound postoperatively at 1 year.

Intervention: arthroscopic rotator cuff repair

Study Group

Identical surgical treatment as control group plus bio-inductive patch implant. Ultrasound postoperatively at 1 year.

Intervention: Bioinductive implant

Study Group

Identical surgical treatment as control group plus bio-inductive patch implant. Ultrasound postoperatively at 1 year.

Intervention: Ultrasound Imaging

Outcomes

Primary Outcomes

Rotator cuff repair integrity

Time Frame: Preoperative to 1 year postoperative

absence of full- or partial-thickness defect as demonstrated on ultrasound at 1-year postoperatively.

Secondary Outcomes

  • PROMs scores for upper extremity function(Preoperative to 2 years postoperative)
  • PROMs scores for upper extremity pain interference(Preoperative to 2 years postoperative)
  • Shoulder Range of Motion(Preoperative to 2 years postoperative)
  • Reoperation(2 years postoperative)
  • PROMs scores for depression(Preoperative to 2 years postoperative)
  • Shoulder Strength(Preoperative to 2 years postoperative)
  • Complications(Intraoperative to 2 years postoperative)

Study Sites (1)

Loading locations...

Similar Trials